Safety and immunogenicity of 2-dose heterologous Ad26.ZEBOV, MVA-BN-Filo Ebola vaccination in children and adolescents in Africa: A randomised, placebo-controlled, multicentre Phase II clinical trial.
Zacchaeus AnywaineHoureratou BarryOmu AnzalaGaudensia MutuaSodiomon Bienvenu SirimaSerge EholieHannah KibuukaChristine BétardLaura RichertChristine LacabaratzM Juliana McElrathStephen C De RosaKristen W CohenGeorgi ShukarevMichael KatwereCynthia RobinsonAuguste GaddahDirk HeerweghViki BockstalKerstin LuhnMaarten LeyssenRodolphe ThiebautMacaya Douoguihnull nullPublished in: PLoS medicine (2022)
ClinicalTrials.gov NCT02564523.